128 related articles for article (PubMed ID: 15456719)
1. Imaging in antiangiogenesis trial: a clinical trials radiology perspective.
Kothari M; Guermazi A; White D; Suhy J; Reinhold C
Br J Radiol; 2003; 76 Spec No 1():S92-6. PubMed ID: 15456719
[TBL] [Abstract][Full Text] [Related]
2. MRI for assessing antivascular cancer treatments.
Padhani AR
Br J Radiol; 2003; 76 Spec No 1():S60-80. PubMed ID: 15456715
[TBL] [Abstract][Full Text] [Related]
3. Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development.
Galbraith SM
Br J Radiol; 2003; 76 Spec No 1():S83-6. PubMed ID: 15456717
[No Abstract] [Full Text] [Related]
4. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.
Leach MO; Brindle KM; Evelhoch JL; Griffiths JR; Horsman MR; Jackson A; Jayson G; Judson IR; Knopp MV; Maxwell RJ; McIntyre D; Padhani AR; Price P; Rathbone R; Rustin G; Tofts PS; Tozer GM; Vennart W; Waterton JC; Williams SR; Workman P
Br J Radiol; 2003; 76 Spec No 1():S87-91. PubMed ID: 15456718
[No Abstract] [Full Text] [Related]
5. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis.
Drevs J; Schneider V
J Intern Med; 2006 Dec; 260(6):517-29. PubMed ID: 17116002
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis modulation in cancer research: novel clinical approaches.
Cristofanilli M; Charnsangavej C; Hortobagyi GN
Nat Rev Drug Discov; 2002 Jun; 1(6):415-26. PubMed ID: 12119743
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenesis: the fifth cancer treatment modality?
Camp-Sorrell D
Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
[TBL] [Abstract][Full Text] [Related]
8. Imaging tumor angiogenesis: the road to clinical utility.
Iagaru A; Gambhir SS
AJR Am J Roentgenol; 2013 Aug; 201(2):W183-91. PubMed ID: 23883233
[TBL] [Abstract][Full Text] [Related]
9. Imaging vascular physiology to monitor cancer treatment.
Laking GR; West C; Buckley DL; Matthews J; Price PM
Crit Rev Oncol Hematol; 2006 May; 58(2):95-113. PubMed ID: 16387510
[TBL] [Abstract][Full Text] [Related]
10. Imaging angiogenesis: applications and potential for drug development.
Miller JC; Pien HH; Sahani D; Sorensen AG; Thrall JH
J Natl Cancer Inst; 2005 Feb; 97(3):172-87. PubMed ID: 15687360
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenesis therapy. Current and future agents.
Kieran MW; Billett A
Hematol Oncol Clin North Am; 2001 Oct; 15(5):835-51, viii. PubMed ID: 11765376
[TBL] [Abstract][Full Text] [Related]
12. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Citrin D; Ménard C; Camphausen K
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
[TBL] [Abstract][Full Text] [Related]
13. The role of imaging in the clinical development of antiangiogenic agents.
Morgan B; Horsfield MA; Steward WP
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1183-206, x. PubMed ID: 15474341
[TBL] [Abstract][Full Text] [Related]
14. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
Gagne P; Akalu A; Brooks PC
Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
[TBL] [Abstract][Full Text] [Related]
15. Imaging the effects of anti-angiogenic treatments.
Vāvere AL; Lewis JS
Q J Nucl Med; 2003 Sep; 47(3):163-70. PubMed ID: 12897708
[TBL] [Abstract][Full Text] [Related]
16. Challenges for imaging angiogenesis.
Padhani AR; Neeman M
Br J Radiol; 2001 Oct; 74(886):886-90. PubMed ID: 11675303
[No Abstract] [Full Text] [Related]
17. Vascular normalization: study examines how antiangiogenesis therapies work.
Webb T
J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
[No Abstract] [Full Text] [Related]
18. Non-invasive assessment of tumor neovasculature: techniques and clinical applications.
Perini R; Choe R; Yodh AG; Sehgal C; Divgi CR; Rosen MA
Cancer Metastasis Rev; 2008 Dec; 27(4):615-30. PubMed ID: 18506398
[TBL] [Abstract][Full Text] [Related]
19. Tumor angiogenesis targeting using imaging agents.
Weber WA; Haubner R; Vabuliene E; Kuhnast B; Wester HJ; Schwaiger M
Q J Nucl Med; 2001 Jun; 45(2):179-82. PubMed ID: 11476168
[TBL] [Abstract][Full Text] [Related]
20. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.
Leach MO; Brindle KM; Evelhoch JL; Griffiths JR; Horsman MR; Jackson A; Jayson GC; Judson IR; Knopp MV; Maxwell RJ; McIntyre D; Padhani AR; Price P; Rathbone R; Rustin GJ; Tofts PS; Tozer GM; Vennart W; Waterton JC; Williams SR; Workman P;
Br J Cancer; 2005 May; 92(9):1599-610. PubMed ID: 15870830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
